http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014530246-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-755 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-726 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-727 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-04 |
| filingDate | 2012-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2014530246-A |
| titleOfInvention | Use of sulfated glycosaminoglycans to improve the bioavailability of factor VIII |
| abstract | The present invention relates to pharmaceutical formulations comprising one or more factor VIII and sulfated glycosaminoglycans for increasing the bioavailability of factor VIII upon non-intravenous administration. Furthermore, the invention relates to the combined use of factor VIII and sulfated glycosaminoglycans for the treatment and prevention of bleeding disorders, thereby improving the bioavailability of factor VIII, and It relates to a method for increasing bioavailability after non-intravenous administration of Factor VIII by co-administering sulfated glycosaminoglycans. |
| priorityDate | 2011-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 82.